メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
第4・婦人科
病院局
岡崎医療センター
概要
フィンガープリント
ネットワーク
研究成果
(41)
フィンガープリント
第4・婦人科が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Gynecologic Oncologist
42%
Corin
42%
Cytomegalovirus Infection
42%
Undifferentiated Carcinoma
42%
Carcinoma Cell Lines
42%
Noninvasive Prenatal Diagnosis
42%
Cervicovaginal Microbiome
42%
Thanatophoric Dysplasia
42%
Cervicovaginal Microbiota
42%
Promising Biomarkers
42%
Carcinogenicity
42%
P16INK4a Immunohistochemistry
42%
Squamous Intraepithelial Neoplasia
42%
Cytological Screening
42%
Spinal Epidural Hematoma
42%
Overeating
42%
Minimally Invasive Therapy
42%
Human Oocyte
42%
Anatomy Imaging
42%
Surgical Anatomy
42%
Cadaveric Study
42%
Intragenic Duplication
42%
Uterine Cervical Adenocarcinoma
42%
ERCC1
42%
Endometrium
42%
Endometrial Carcinoma
42%
Placenta
42%
Fetal Growth Restriction
42%
Estrogen Depletion
42%
Nectin-4
42%
Herbal Formulation
42%
Hachimijiogan
42%
Atypical Squamous Cells of Undetermined Significance (ASC-US)
42%
Japanese Gynecologic Oncology Group
42%
Immunohistochemical Analysis
42%
Cytokine Expression Profile
42%
Induction of Labor
42%
Ovarian Carcinosarcoma
42%
Cervical Gland Area
42%
P16INK4a/Ki-67
42%
Repeated Recurrence
42%
Post-term Delivery
42%
HPV 52
36%
Achondroplasia
35%
Past Users
32%
Parametrium
32%
Cadaver
32%
HMSH2
28%
Hyperplasia
28%
Microvascular Invasion
28%
Microsatellite Instability-high (MSI-H)
28%
Local Surgery
28%
No Significant Difference
28%
Endometrioid
28%
TP53 mutation
28%
Histological Subtypes
28%
Lymph Node Metastasis
28%
KRAS mutation
28%
HMLH1
28%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
24%
Tumor
22%
Certification System
21%
Three-dimensional Reconstruction Model
21%
Exome Sequencing
21%
Female Pelvis
21%
Human Cytomegalovirus
19%
L-cells
17%
TC Chemotherapy
17%
Cohesion
16%
MiR-126-3p
16%
Endometrioid Carcinoma
14%
Biological Characteristics
14%
Endometrioid Adenocarcinoma
14%
Mechanisms of Carcinogenesis
14%
Persistent HPV Infection
14%
Cervicovaginal
14%
Atopobium Vaginae
14%
Protein Expression
14%
HPV Clearance
14%
HPV Genotyping
14%
Ureaplasma
14%
Stage III-IV
14%
Pearson's chi-square Test
14%
Chronic Cervicitis
14%
HSIL Cytology
14%
Vascular Hemodynamics
14%
Progressive Paralysis
14%
Visceral Fat Mass
14%
Clear Cell Type
14%
Serous
14%
FIGO Stage
14%
P53 Expression
14%
Decreased Ovarian Function
14%
Immunohistochemistry
14%
Worse Prognosis
14%
Type II Endometrial Carcinoma
14%
Nulligravida Women
14%
Transvaginal Ultrasonography
14%
Cervical Length
14%
Bishop Score
14%
Medicine and Dentistry
Obstetrics
51%
Cervical Cancer
42%
Endoscopy
42%
Oncologist
42%
Minimally Invasive Procedure
42%
Vaginal Ultrasonography
42%
Cervical Length Measurement
42%
Anaplastic Carcinoma
42%
Pre-Eclampsia
42%
Tamoxifen
42%
Endometrium Carcinoma
42%
Carcinoma Cell Line
42%
Nectin
42%
Carcinogenicity
42%
Thanatophoric Dwarfism
42%
Fibroblast Growth Factor Receptor 3
42%
Uterine Cervicitis
42%
Spinal Hematoma
42%
microRNA
42%
Imaging Anatomy
42%
Wart Virus Vaccine
42%
Endometrium
42%
Robot-Assisted Surgery
42%
Gynecological Oncology
42%
Diagnostic Marker
42%
Hachimijiogan
42%
Precursor
42%
Carcinosarcoma
42%
Mucus
42%
Achondroplasia
35%
Protein P53
32%
Parametrium
32%
Cadaver
32%
Neoplasm
31%
Lymph Node Metastasis
30%
Vaginal Delivery
28%
Tuberous Sclerosis
25%
Cell Line
25%
microRNA 126
22%
Hyperplasia
21%
Three-Dimensional Reconstruction
21%
Microsatellite Instability
21%
Ras Signaling
21%
Malignant Neoplasm
18%
Decidua
17%
Laparoscopic Surgery
17%
Pelvic Examination
14%
Medical Intervention
14%
Primiparous Woman
14%
Ovary Function
14%
Radical Hysterectomy
10%
Adenocarcinoma
10%
Incentive
10%
Endometrioid Carcinoma
10%
Clear Cell
10%
Protein Expression
10%
Genetic Prenatal Diagnosis
10%
Pulmonary Hypoplasia
10%
Exome
10%
Respiratory Distress
10%
Newborn Death
10%
Sanger Sequencing
10%
Carcinogenesis
10%
Immunohistochemistry
10%
Gynecology
8%
Surgeon
8%
Placenta
8%
Syncytiotrophoblast Cell
8%
Gestational Hypertension
8%
Alpha Catenin
8%
SCID Mouse
8%
Salpingooophorectomy
8%
Lymph Node Biopsy
8%
Primary Tumor
8%
Signet Ring Cell
8%
Pelvic Magnetic Resonance Imaging
8%
Cell Contact
8%
Uvomorulin
8%
Gestagen
8%
Progesterone Derivative
8%
Endometrial Biopsy
8%
In Vitro
8%
Chromosome Analysis
8%
Aneuploidy
8%
Aggression
8%
Carboplatin
8%
Adhesive Agent
8%
Cytoreductive Surgery
8%
Rhabdomyosarcoma
8%
Cell-Free Fetal DNA
7%
Vagina Bleeding
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Screening Test
6%
Cervical Intraepithelial Neoplasia
6%
Cytotechnology
6%
Screening
6%
Endometrial Polyp
5%
Drug Rapid Test
5%
Immunology and Microbiology
Precursor
100%
Nectin
85%
Quantitative Reverse Transcription Polymerase Chain Reaction
71%
Fetus Growth
55%
Upregulation
46%
Cytokine
42%
Low Drug Dose
42%
Cell Line
42%
Carcinoma Cell Line
42%
Cancer Cell
42%
Eclampsia
42%
Screening
42%
Chemosensitivity
42%
Everolimus
42%
Excision Repair
42%
Screening Test
42%
Squamous Cell
42%
Wart Virus
37%
Decidua
17%
Fat Mass
17%
Granulocyte Macrophage Colony-Stimulating Factor
15%
RANTES
15%
Gene Expression
14%
Catenin
14%
Lymph Node
14%
Cell Contact
14%
SCID Mouse
14%
Cadherin
14%
Maternal Serum
12%
Syncytiotrophoblast Cell
8%
Ureaplasma
8%
Atopobium vaginae
8%
Monocyte Chemotactic Protein 1
7%
Cell Growth
7%
Eotaxin
7%
Interleukin 17
7%
Blood Level
6%
Cell Adhesion Molecule
6%
Placenta
6%
Adherens Junction
6%
Tight Junction
6%